Target intelligence / Profile preview

PSG11, PSG2 and PSG5 antisense RNA 1 (PSG11-AS1)

Target: PSG11-AS1
Molecular classification: Long non-coding RNA, Antisense RNA

Overview

PSG11-AS1 is a long non-coding antisense RNA transcribed from a region antisense to the PSG11, PSG2, and PSG5 genes. There is no current evidence that PSG11-AS1 encodes a protein or acts as a classic therapeutic target, and no experimental data are available regarding its biological function, involvement in disease, or utility as a clinical biomarker. It is catalogued as a lncRNA of unknown function.

Other names: AC004784.1CTC-490G23.6PSG11-AS1

Beyond the preview

Go deeper on PSG11, PSG2 and PSG5 antisense RNA 1 (PSG11-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSG11, PSG2 and PSG5 antisense RNA 1 (PSG11-AS1).

Explore the full profile